Skip to main content
Log in

Final NCD for recombinant erythropoietins released in the US

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Centers for Medicare and Medicaid Services.Medicare Posts Final National Coverage Determination for the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions. Media Release: 30 Jul 2007. Available from: URL: http://www.cms.hhs.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Final NCD for recombinant erythropoietins released in the US. Pharmacoecon. Outcomes News 534, 10 (2007). https://doi.org/10.2165/00151234-200705340-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705340-00032

Keywords

Navigation